• Cryptocurrency that Cares

    I interviewed the top minds in the Bitcoin world about how nonprofits can benefits from this digital currency. Click here to learn more.

  • Writing and Publications

    Digital Strategy, Innovation, Co-Creation, Crowdfunding, Nonprofits, Volunteerism, Advocate Programs and Bitcoin are my passions. I often get to write about them. Click here to read more.

  • Speaking

    I've been keynoting and speaking at a variety of conferences for the last eight years. I'd love to hear more about yours. Click here to learn more.

When big boys–and girls–go shopping

The tech giants picked up some significant trinkets over the weekend. Of most direct interest to ACS is the purchase of Siebel Systems by Oracle ($3.6 B). ACS uses the Siebel CRM system. So how long before we get to choose between switching to Oracle or live with an unsupported software system? Then Meg Whitman and eBay bought up Skype ...

Read More »

Katrina's destruction may spread to nonprofits

An article in the LA Times suggests that the ripples from hurricane Katrina may hit NPOs as far away as California. The outpouring of generosity to Katrina survivors and the Red Cross is being diverted from other charitable causes. Already there are signs that the unprecedented generosity directed at victims of Hurricane Katrina is having an effect on nonprofit groups ...

Read More »

Google Will Rule the World

Amid all the Katrina news, last week google introduced yet another new service. This one is basically google IM. Google Talk enables you to call or send instant messages to your friends for free–anytime, anywhere in the world. It’s pretty cool and reminds me of Skype combined with AOL. If anyone wants to try it out let me know and ...

Read More »

Biomarkers

A lot of hope for really early detection of cancers is pinned on finding molecular indicators of them–ie, biomarkers. Here’s an update from a Technology Review article: Many of today’s tools for screening and diagnosing cancer are crude at best. So researchers are working to find more-sensitive tests based on specific molecules–called "biomarkers"–that are early signs of tumors and whose ...

Read More »